Clinical Trial Update: Efficacy and Safety of T-DXd in HER2-mutant Advanced Lung Cancer Patients With Asymptomatic Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial update on the efficacy and safety of trastuzumab deruxtecan (Enhertu) in HER2-mutant advanced non-small cell lung cancer, including patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)

Snippet

Sponsor: Yonsei University | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: ENROLLING_BY_INVITATION